chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a consumer concerning her daughter, a 26 year old female with anxiety disorder and penicillin allergy who on 04-AUG-2008 was vaccinated with the first dose of GARDASIL. Concomitant therapy included escitalopram oxalate (LEXAPRO). On 04-AUG-2008, several hours after received the first dose, the patient experienced heart palpitations. On 05-AUG-2008, the patient improved but experienced the onset of chills, diarrhea and nausea. The nausea improved, but on 07-AUG-2008, the patient began to have widespread body aches and a headache in addition to the continuing diarrhea. The patient contacted her physician's office by phone and was advised to call again if the symptoms persist. No therapy was prescribed. The patient improved from nausea. At the time of reporting, chills, diarrhea and widespread had not recovered. The reporter states the physician does not feel that patient's symptoms are related to GARDASIL vaccine.  Additional information is not expected as the consumer did not provide the physician's name
COVID POSITIVE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced covid positive. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid positive was not reported. This report was non-serious. This report was associated with a product quality complaint: 90000203024.
Second shot was administered at 1ml and should have been 0.5 ml.  No symptoms noted at this time.
having some mild heart pain that fades away; had a mild heart pain and moderate pain in the chest; wife also had blood in he mouth. She was coughing up blood; This is a spontaneous report from a contactable consumer (patient's husband). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 22May2021 (lot number and expiry date: unknown) as dose 1, single, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of the Pfizer COVID-19 vaccine. On 23May2021 (second day), she had a mild heart pain and moderate pain in the chest for 1-2 days. The adverse events already decreased and faded away. On unspecified date in May2021, the patient also had blood in the mouth. She was coughing up blood. It was a one-time event. The husband reported that his wife (patient) wanted to know if she would have these adverse events with the second dose of the vaccine. Outcome of the events was recovered on unspecified date in May2021.  Information on lot/batch number has been requested.
Nurse was asked to come help a patient that felt dizzy after getting the vaccine. Nurse walked over and she was being held up by other nurses. Patient never hit her head but she lost consciousness and had jerky movements for about 10 seconds. After coming to, she could tell us her name and where she was accurately. Nurses took vital signs that were stable after event. She was taken to a holding area by wheelchair and given water/food. She said she felt much better and left 30 minutes later on a bus.
Wife has a red spot on arm a week after shot; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (Wife has a red spot on arm a week after shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ERYTHEMA (Wife has a red spot on arm a week after shot). At the time of the report, ERYTHEMA (Wife has a red spot on arm a week after shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   ? No treatment information was provided.   Reporter did not allow further contact
About 2-3 days after my vaccination, I started having chest tightness in my central chest. No shortness of breath (apart from discomfort due to the tightness). I did not have any other symptoms at that time (e.g. fevers, cough, muscle/body aches). Over the next 5-6 days, the tightness moved progressively upwards into my upper chest, then my lower esophagus, then into my neck before spontaneously resolving.
Headache worse than a migraine for 3 hours will headache after for day and a half. Fever as high as 101.4 low grade fever for day and a half.
1.Client signed consent form herself even though under 18.  2. Client received Janssen vaccine even though under 18.
After patient received both injections, she got light headed and slid out of chair to floor. She was "white" complexion but never passed out. After 5 minutes and a glass of water she was fine.
PT given 2 IPV immunz 1 single dose and 1 combo with Hep B which was not needed.
loss of vision; shingles; other zoster-related conditions; postherpetic neuralgia; This initial spontaneous report was received on from a lawyer regarding a case in litigation and refers to a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medication were not provided.   On or about 09-OCT-2014, the patient was vaccinated with a dose zoster vaccine live (ZOSTAVAX) (dosage regimen was not reported) for the long-term prevention of shingles (herpes zoster).  On an unspecified date, subsequent to the patient vaccination, the patient was treated by a physician for the following injuries resulting from the zoster vaccine live (ZOSTAVAX) vaccination: Shingles, other zoster-related conditions (ill-defined disorder), post herpetic neuralgia and loss of vision. At the reporting time, the outcome of the events was unknown.  The reporter considered the events of Shingles, other zoster-related conditions (ill-defined disorder), post herpetic neuralgia and loss of vision to be related to zoster vaccine live (ZOSTAVAX).  Upon internal review the event of loss of vision was considered as medically significant.
Ongoing serious fatigue often accompanied by weakness and dizziness  Almost every single day over the past month I have felt awful and struggle to complete my daily responsibilities. I was an extremely healthy, athletic individual 5'4" 114" and haven't had any other vaccines since 2 travel immunizations 5 years ago. Nothing else about my lifestyle has changed.
COVID Breakthrough case Symptoms began: 05/08/21 Lab confirmed: 05/13/21
Patient had arm numbness that started 30 minutes after the vaccine. The arm numbness started in the shoulder to the elbow and then gradually her whole arm and hand was numb.   The numbness in the arm decreased as of 03-11-21 and patient reporrted that the numbness is from her shoulder to her bicep only.   Additional information provided to pharmacist immunizer by nurse at facility: patient was prescribed prednisone at her visit to urgent care on day of event.
Arm muscle ached; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN5318), via an unspecified route of administration on 23Mar2021 at 13:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not tested for COVID-19. On 23Mar2021 at 23:00, the patient experienced arm muscle ached. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment was taken for the adverse event. The clinical outcome of arm muscle ache was resolved on unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Initial report received from a health care provider on 29 September 2009. A 23 year-old female patient reported that she was vaccinated with FLUZONE (sanofi pasteur, Lot # U2363AA) and H1N1 (sanofi pasteur, Lot # UP001AA) on 29 September 2009. Later in the afternoon (approximately 4:00 PM) of the day of vaccination, the patient reported cough, wheezing, sore throat and bloodshot eyes. It was also reported that she was getting over a cold at the time of vaccination. The outcome was not reported. No further information is expected. Follow-up information received 28 October 2009 from a health care professional. The outcome for the symptoms of cough, wheezing, sore throat and bloodshot eyes was reported as two days. According to the reporter, the events did not require a doctor's visit. List of documents held by sender: none.
DEATH; This spontaneous report received from social media via a company representative concerned a male of unspecified age, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry were not reported) dose, start therapy date were not reported administered 1 in total for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient died from unknown cause of death. It was not reported if an autopsy was performed or not. Reporter reported that "The jab killed my dad. So your building has his blood on it. How do you sleep at night". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20221107887-Death. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
While waiting in the observation area and approximately 10 minutes after receiving the injection, I felt a strange wave come over me and I became very lightheaded and felt weird all through my body. I can't really explain the sensation.  I passed out and when I came to, I was very weak. The staff at the facility gave me oxygen and took my blood pressure.  They called the paramedics. The parademics did an EKG which was normal and they took me to the ER for some other routine testing, which was all normal and then I was released. Since then, I have felt a bit nauseous and tired.
Patient c/o of a warm flush feeling, tight throat and dizziness. Pulse to 146. Treated  with two 25 mg Benadryl capsules
76 yo female with PMHx of CAD s/p CABG 2016, abdominal aortic aneurym, HTN, HLD, Asthma, Diverticulosis, Osteopenia. Presenting to the ED after having Pre-syncope.  She reported that today morning she felt nauseated with episode of vomiting,  burping and abdominal discomfort after having her lunch meal, headed out to receive her vaccine, she felt well till 10 minutes after the vaccine where a nurse noticed she is pale and less responsive, BP was measured back then and was ~70 ?, the patient reported that she was sitting when that happened, she felt lightheaded, sweating, blurry vision, nauseated. But denies any chest pain, sob, palpitation, weakness or numbness. She was out of balance and feeling weak till she came to the ED where she felt better after IV fluids.
The patient's upper right arm swelled and became irritated, red, and raised. The patient noted it was painful. No other symptoms were present.
tested positive for COVID-19 after being vaccinated/Tested positive yesterday; tested positive for COVID-19 after being vaccinated/Tested positive yesterday; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as first dose at single dose, then via an unspecified route of administration on 21Apr2021 (Batch/Lot number was not reported) as second dose at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient wanted to inform that he/she is one of the 0.02% who tested positive for COVID-19 after being vaccinated. The patient tested positive yesterday (May2021) and had the second dose on 21Apr2021. The outcome of the events was unknown.   Information about lot/batch number has been requested.
Generalized rash, red papules on head, abdomen,back,buttocks, legs.
33 y/o with no past medical history presents with dizziness and palpitations post vaccination Patient states that this is the second dose in the two-dose series. Patient denies reaction to previous vaccination. Patient states that vaccination was received to the left arm. Patient states that currently on a low carb/low sugar diet. Patient placed in wheelchair and taken to partitioned area with NP and Paramedics. Patient vitals consistent with hypertension and tachycardia, EKG with sinus tachycardia (168/94 BP, 112 HR, 100% RA, Resp 14). Glucose 86. Patient placed in Trendelenburg position. Patient monitored for over 50 mins with fluctuations of feeling better then resumption of dizziness. Patient vitals normalized but dizziness remained. Fire rescue called and assessed patient. Patient stated that he still felt dizziness but was ok to go home. Patient didn?t want to be transported to the ER. Patient signed Against Medical Advice, CNP and PM aware. Patient left site on his own accord.
pt recv vax 24FEB96 & was not seen but pt mom reports less than twenty lesions & pt recovered in less than 5 days;
After receiving vaccination patient became incoherent, began having difficulty breathing and was audibly wheezing. Skin became extremely pale.  Epinephrine was administered and 911 was called. EMS evaluated the patient and patient declined further medical attention.
Area around injection site swollen, warm, itchy, and sensitive to touch. Sort if like a large bug bite. Symptom still persists today.
Day of vaccine: sore arm at vaccine site. Second day: Total body fatigue, Light headed, Balance could not stand or walk alone, slept all the following day, no appetite, diarrhea.  These lasted the entire second day. Third day: fatigue, light headed, could not stand or walk alone, slept most of the day.  Slightly better appetite. Fourth day: appetite is better, he can stand and walk although not very well.  Still weak. Improving  slowly.
Pt got MENACTRA injection 071808, woke up 071908 with hives all over body and really sore arm at injection site. Went to clinic at University and was given steroid shot. Was unable to go to work 071908. As of 072008, hives were gone. As of 072508 still c/o soreness at injection site.
Fever 102, bodyaches, diarrhea, and Tinnitus  TINNITUS started in left ear and right ear and now bilaterally and it is getting worse.  Tinnitus is associated with headache and dizziness that  has worsened since onset of 4/9/2021.
On the same day of vaccine in the night I started to have chills & body ache. They lasted through the next day they lasted for about 18hrs.
Patient had received Moderna as the first dose at another vaccination site for Covid-19 vaccination. We mistakenly gave the patient a Pfizer/BioNTech vaccination for the second dose in the series, where patient was supposed to have received Moderna for their second dose.
Has been a little sleepy; Swollen stomach; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported), via an unspecified route of administration on Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that her husband (patient) seems fine but has been a little sleepy and has a swollen stomach on an unspecified date. The outcome of the events was unknown.  Information on Lot/Batch number has been requested.
Strange sensation running down front of body.  Skin w/d, no breathing diff.  Stated face felt weird, tongue not swollen.
Pain in Rt arm on at injection site continues can still see puncture at site pain from shoulder to elbow unable to lift or carry or sweep no fever chills or redness site jerks red when heat applied. Pt has seen PMD x 3.
Flu like symptoms for two or three days.  Unable to do regular activities.  Large red rash over upper arm down to elbow.  Still have rash after 7 days from injection.  Tenderness and pain around injection site for four days.
heart condition; taken the second dose of the Pfizer COVID-19 vaccine 2 weeks after the first dose of the vaccine (instead of 3 weeks); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CARDIAC DISORDER (non-serious), outcome "unknown", described as "heart condition"; "INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious), outcome "unknown", described as "taken the second dose of the Pfizer COVID-19 vaccine 2 weeks after the first dose of the vaccine (instead of 3 weeks)".  Additional Information: Caller was calling from her friend who has a heart condition and has taken the second dose of the Pfizer COVID-19 vaccine 2 weeks after the first dose of the vaccine (instead of 3 weeks). Caller would like to know if it would cause any effect. DSU: AE realized after the call.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Information has been received from a medical assistant and a physician concerninga 26 month old male who is a nonsmoker who on 3/15/01 was vaccinated in the right thigh with a first dose of Haemophilus B conjugate vaccine (+) hep B vaccine recombinant (637766/1586K); on 5/29/01 he was vaccinated in the left thigh with a second dose of Haemophilus B conjugate vaccine (+) hep b vaccine recombinant (637766/1586K), and on 3/25/02 he was vaccinated in the right thigh with a third dose of Hameophilus B conjugate vaccine (+) hep B vaccine recombinant (638594/1824K). The pt completed the series on 3/25/02. On 3/31/03 a Hepatitis BSAb test was done with a result of 4 MIU/ML. On 4/9/03, it was reported that a titer done "last week" was negative for antibodies and that the pt was given a blood test and he was found "not to be immune to hep B or Haemophilus B." It was reported that the pt received the three doses of the vaccine according to the appropriate dosing schedule. Unspecified medical attention was sought. No product quality complaint was noted. No further info is expected.
Received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received dose from vials beyond 30-day use by date) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received dose from vials beyond 30-day use by date). On 18-Jun-2021, EXPIRED PRODUCT ADMINISTERED (received dose from vials beyond 30-day use by date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported. Refrigeration date is 07 May 2021.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine beyond its use by date.), PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 30-Jun-2022 and administered on 05-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 63-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B22A) for COVID-19 prophylaxis. It was unknown if patient had any allergies, any acute or chronic illnesses at the time of vaccination. It was unknown if any other vaccines were given to the patient within 1 month prior to Moderna COVID-19 vaccine. It was unknown if patient ever had COVID positive test or diagnosis. On 05-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine beyond its use by date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 30-Jun-2022 and administered on 05-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine beyond its use by date.), PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 30-Jun-2022 and administered on 05-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine beyond its use by date.) and PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 30-Jun-2022 and administered on 05-Aug-2022). No concomitant medications were reported. The patient had received second booster. The vial was initially stored in the refrigerator on 30-Jun-2022. Reportedly, the vial did not undergo any temperature excursions.  It was unknown if the adverse event caused patient to seek medical care. It was unknown if the patient experienced a similar event in the past. No treatment information was provided by the reporter.
Left arm and shoulder pain radiating to left hand with weakness , throbbing sharp  radiating pain  to left hand.
Lot# 053E21A administered outside the 30-day use by date. A case was opened with Moderna ID Case ID CEA-1261. "The vaccine administered maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
5 minutes after vaccine given patient started having facial numbeness, throat tightness, headache, foggy vision. Vital signs remained stable and patient in no acute or respirator distress. Monitored patient for 30 minutes and symptoms resolved except still slight foggy vision. patient stated she felt better and able to see well.